The Healthcare Cloud Infrastructure Market is expected to register a valuation of US$ 464.1 Billion by 2033 at a CAGR of 23.9%, according to a recently published Future Market Insights report. The market through healthcare cloud infrastructure services is projected to grow at a CAGR of 23.7% from 2023 to 2033. The market is growing …
Category Archives: Healthcare Trends
Human Immunodeficiency Virus Type 1 (HIV 1) Market is expected to reach a valuation of US$ 62.37 Billion by 2033 | FMI
The global Human Immunodeficiency Virus Type 1 (HIV 1) Market is predicted to exceed a remarkable valuation of US$ 34.83 Billion in 2023, with a compound annual rate of growth (CAGR) of 6% estimated from 2023 to 2033. The Institute for Health Metrics and Evaluation attributes the industry’s growth to the soaring incidence rate of …
South Korea light therapy market is projected to reach a valuation of US$ 1.8 Billion by 2033
According to Future Market Insights (FMI), light therapy remains a very significant trend for the South Korean government and the scope of opportunities is expected to be limited. However, with the penetration of social media and recognition of its medical health benefits, sales of light therapy are expected to continue to grow at a steady …
Increased funding and expenditure in pharmaceuticals and biotechnology R&D procedures are propelling the Laboratory Supplies industry in South Korea
The South Korean Laboratory Supplies Market is predicted to reach US$ 1 billion by 2032. The market is primarily driven by increased funding and investment in pharmaceutical and biotechnology R&D operations. Because of the consistent and predictable supply of laboratory equipment, the market is projected to expand at a steady rate over the next several years. The …
Popularity of Biopsy Devices in Minimally Invasive Procedures to Create Lucrative Opportunities for European Manufacturers | Introduction of Reimbursement Policies to Act as Catalyst
According to Future Market Insights (FMI), the U.K. Biopsy Device Market is poised to expand at a CAGR of 3.9% during the assessment period, reaching a valuation of US$ 159 Million by 2033. Germany’s biopsy device market is likely to accelerate at a CAGR of 4.1% during the anticipated timeframe with overall sales anticipated to hit a total of US$ 236 Million by the end …
Eltrombopag and Romiplostim Therapies Emerging as Effective Second-Line Chronic Immune Thrombocytopenia Treatment | FMI Predicts Korea to Remain a Key Revenue Generation Market
Future Market Insights in its latest report predicts Korea Thrombocytopenia Treatment Market to progress at around 3.5% to 4.0% CAGR between 2023 and 2033. Sales of thrombocytopenia medication in the global market are slated to rise at a CAGR of 5.2% throughout the forecast period (2023 to 2033). Introduction of new treatments and medications for thrombocytopenia in Korea has the potential …
Demand for Monoclonal Antibodies and RNA Vaccines to Drive Cholesterol API Market Across Europe | Germany to Register 4.9% CAGR States FMI
The global Cholesterol Active Pharmaceutical Ingredient (API) Market is projected to be valued at US$ 269.0 Million by the end of 2022, and to grow at a CAGR of 4.7% between 2022 and 2032. By 2032, the global market for cholesterol API is expected to be worth US$ 426.9 Million. Germany is predicted to remain the most …
Balloon Catheter Market exhibit a revenue growth of US$ 6.4 Billion by 2033
According to Future Market Insights (FMI), the U.K. Biopsy Device Market is poised to expand at a CAGR of 3.9% during the assessment period, reaching a valuation of US$ 159 Million by 2033. Germany’s biopsy device market is likely to accelerate at a CAGR of 4.1% during the anticipated timeframe with overall sales anticipated to hit a total of US$ 236 Million by the end …
Continue reading “Balloon Catheter Market exhibit a revenue growth of US$ 6.4 Billion by 2033”
Hematopoietic Stem Cell Transplantation to Hog Limelight in Europe from 2023 to 2033 | FMI Foresees a Healthy 7.6% CAGR
As per the report published by Future Market Insights (FMI), the Hematopoietic Stem Cell Transplantation (HSCT) market in Europe is projected to accelerate at a CAGR of 7.6% from 2023 to 2033. Leukemia and lymphoproliferative disorders are among the most common types of medical conditions in Europe and reported cases have been steadily rising in recent years. This trend …
Korea’s Development of Petconomy is Changing the Way Companion Animal Specialty Drug Manufacturers Operate
South Koreans are expected to spend US$ 3 billion on their pets in 2020 and more than US$ 3.5 billion in 2021, resulting in an increase in pet-related businesses in Korea. According to the Korea Rural Economic Institute, this figure is expected to reach US$ 5 billion by 2027, creating opportunities for Korea’s companion animal specialty …